TG Therapeutics Secures $500M, Expands Buyback to $300M

Edgen Stock·Mar 19 2026, 12:07

Share to

Share to

Copy link

Key Takeaways

TG Therapeutics has significantly bolstered its financial position through a dual strategy of raising capital and increasing shareholder returns. The company secured $500 million in non-dilutive financing from Blue Owl while simultaneously expanding its share repurchase authorization to $300 million, signaling strong confidence in its future prospects.

TG Therapeutics secured $500 million in non-dilutive financing, strengthening its balance sheet without issuing new stock.
The company expanded its share repurchase program to $300 million, a move that can increase earnings per share.
These actions provide capital for strategic initiatives and signal management's belief that the company's stock is undervalued.

TG Therapeutics Secures $500M Without Diluting Shareholders

On March 19, 2026, TG Therapeutics announced a major capital infusion, securing an additional $500 million in non-dilutive financing from capital provider Blue Owl. This strategic move provides the company with significant financial flexibility without diluting the ownership stake of current shareholders. The capital is structured to support both operational initiatives and opportunistic investments, strengthening the company's balance sheet for future growth and strategic deployment.

In a concurrent announcement that signals strong management confidence, TG Therapeutics expanded its share repurchase program to a total of $300 million. This decision allows the company to opportunistically buy back its own shares from the open market. Share repurchase programs are a direct way to return capital to shareholders, as they reduce the number of outstanding shares and, as a result, can increase earnings per share (EPS). This move suggests leadership believes the company's stock is currently undervalued and represents an attractive investment.

TG Therapeutics Secures $500M Without Diluting Shareholders

Company Expands Share Buyback Program to $300M